Immunome
IMNM
#4429
Rank
C$3.32 B
Marketcap
C$30.11
Share price
-3.09%
Change (1 day)
113.77%
Change (1 year)

Market capitalization of Immunome (IMNM)

Market cap: C$3.32 Billion

As of February 2026 Immunome has a market cap of C$3.32 Billion. This makes Immunome the world's 4429th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunome from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.32 B1.28%
2025C$3.28 B247.49%
2024C$0.94 B55.67%
2023C$0.60 B1567.24%
2022C$36.37 M-81.8%
2021C$0.19 B53.61%
2020C$0.13 B

End of Day market cap according to different sources

On Feb 17th, 2026 the market cap of Immunome was reported to be:

C$3.42 Billion
by Nasdaq info icon info icon
C$3.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
C$1.44 B-56.53%๐Ÿ‡บ๐Ÿ‡ธ USA